Biomark Capital Management

Latest statistics and disclosures from Biomark Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ADMA, Mabvax Therapeutics Holdings, and represent 100.00% of Biomark Capital Management's stock portfolio.
  • Biomark Capital Management has $8.9M in assets under management (AUM), dropping by 37.59%.
  • Central Index Key (CIK): 0001667082

Tip: Access up to 7 years of quarterly data

Positions held by Biomark Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Biomark Capital Management

Biomark Capital Management holds 2 positions in its portfolio as reported in the September 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Adma Biologics (ADMA) 100.0 $8.9M 1.4M 6.21
 View chart
Mabvax Therapeutics Holdings 0.0 $4.0k 8.9k 0.45
 View chart

Past Filings by Biomark Capital Management

SEC 13F filings are viewable for Biomark Capital Management going back to 2015